Clinicopathological characterization indicated that PKM2 or ITGA3 overexpression was associated with age, serum AFP, TNM stage, BCLC stage, tumor number, tumor size, and microvascular invasion (Table 1). This evidence concerns the gene PKM and neoplasm.